KinderPharm Raises $1 Million to Further Advance Pediatric Drug Development

KinderPharm, a full-service contract research organization (CRO) dedicated exclusively to pediatric drug development, has raised $ 1 million from a Series A comprised of individuals, companies and angel investors. The $ 1 million investment will be used to further advance the clinical development of new medicines for children. [PR.com]
PR.com Press Releases: Medical & Health: Pharmaceuticals News

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us